# Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

> **NCT06563323** · PHASE2 · RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 17 (estimated)

## Conditions studied

- Pyoderma Gangrenosum
- Skin Diseases
- Wound Heal
- Pyoderma
- Skin Ulcer

## Interventions

- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT06563323
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2027-08-13
- **Final completion:** 2027-08-13
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06563323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06563323, "Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06563323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*